Mutant Huntingtin Gene-Dose Impacts on Aggregate Deposition, DARPP32 Expression and Neuroinflammation in HdhQ150 Mice

• Douglas Young,

  Current address: Institute of Photonics, University of Strathclyde, Glasgow, Scotland, United Kingdom

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Franziska Mayer,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Nella Vidotto,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Tatjana Schweizer,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Ramon Berth,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Dorothee Abramowski,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Derya R. Shimshek ,

  * E-mail: derya.shimshek@novartis.com (DS); PeSchmid@aol.com (PS)

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• P. Herman van der Putten,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Peter Schmid

  * E-mail: derya.shimshek@novartis.com (DS); PeSchmid@aol.com (PS)

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience, Novartis Pharma AG, Basel, Switzerland

  ⨯